Abiopharma

🔍 Platford Giles Richard (Executive)

Company: TAKEDA PHARMACEUTICAL CO LTD (TAK)

Report Date: 2026-04-27

Detailed Transactions and Holdings:

• Acquired 72,124 shares of American Depositary Shares (Direct)
  Date: 2026-04-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 297,363.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones. On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above.
• F2: Includes 166,744 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (116,762 shares), July 1, 2027 (32,396 shares) and July 1, 2028 (17,586 shares).